FDA Inspection
Carter BloodCareCarter BloodCare – FDA Inspection, Aug 25, 2017
Record Details
This FDA Inspection record concerns Carter BloodCare, with an inspection on August 25, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 7c649d44-390b-4689-b634-469600b3fd89
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1023814
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Carter BloodCare
5| Date | Classification | Office | Project area |
|---|---|---|---|
| July 21, 2026 | Not classified | Dallas District Office | |
| May 23, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 10, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 13, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 13, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Carter BloodCare
- FDA Inspection 1329542 - 2026-07-21
- FDA Inspection 1092617 - 2019-05-23
- FDA Inspection 938894 - 2015-07-10
- FDA Inspection 818232 - 2013-02-13
- FDA Inspection 706855 - 2011-01-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.